Biochemist Glimcher Cited For Hard-Tissue Research

Surgeons know that some of the most painful, costly, deadly diseases could be prevented or reversed if only medical science understood the molecular structure of phosphated proteins and their interaction with calcium. No surprise then that Melvin Glimcher—who has been responsible for a number of extraordinary research breakthroughs in this area—would become the first person to receive the Bristol-Myers/Zimmer Award for Distinguished Achievement in Orthopaedic Research. Glimcher dir

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Glimcher director of the Laboratory for the Study of Skeletal Disorders and Rehabilitation at Children’s Hospital, Boston, and Harriet M. Peabody Professor of Orthopaedic Surgery at the Harvard Medical School, received the $25,000 award in recognition of his studies of how bones, teeth, arteries, and other tissues harden in the human body. He has identified five basic steps that lead to the hardening of tissue, as well as more than 10 unique combinations of phosphorus and proteins that attract calcium. Selected by an independent panel of leading orthopedic surgeons, Glimcher received the award during the American Orthopaedic Association annual meeting earlier this summer.

“The hardening of tissue is such a basic physical development in living creatures that the immense implications of Dr. Glimcher’s work are hard to grasp,” says Clement Sledge, a colleague of Glimcher’s at Harvard Medical School. “He is a pioneer in examining the molecular structure of phosphated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies